US, UK, Scotland & Netherlands Concerns about Gardasil

May 24, 2009

To the esteemed members of the Robert Koch Institute and Health Minister of Germany:

The attached paper has been prepared by concerned individuals from the United Kingdom, United States of America and Holland in regards to the safety and efficacy of the HPV vaccines.

We intend to prove that the serious health concerns that are becoming evident due to Gardasil and Cervarix around the world are valid.  You will see that the studies themselves will prove the lack of efficacy and the increased risks to the health of our young people.  Also entered into this report are communications with the lead researcher for both Gardasil and Cervarix.  Included are reports of young girls and women who have had serious adverse effects and deaths with unknown etiology from America and Europe.   Attached is a video of Karen Maynor who lost her daughter after receiving the Gardasil vaccination.  This mother is trying to come to terms with the fact that the post mortem determination is unknown.

We also want you to know that an inquiry was done by the researchers in the United States as to the overall health and activity level of the affected young people pre-vaccination.  The results of the inquiry and investigation that ensued are startling.  It has been determined that the young people most likely to be affected are very active, athletic and high achievers or have a serious weight problem.  A subset of the affected received the vaccination when they were at the pre-menstrual time of their cycle.  What these three groups have in common is that estrogen, which we know protects the brain from stroke, is decreased leaving the brain more susceptible to damage of the capillaries and the neurotoxin aluminum.

We are aware that you are questioning the effectiveness of Cervarix.   Thousands of young girls and women are experiencing severe adverse events and their quality of life is vastly diminished around the world from Gardasil and Cervarix HPV vaccines.  Could you please also look at the bigger picture in regards to the safety of our children and take into account the many comments which have been made.

We do so hope you will read our submission and if you wish to ask any questions of the authors, email addresses have been provided.  We do so hope that you will give serious consideration to our many concerns in regards to the safety and efficacy of both HPV vaccines.


Cynthia Janak
Research Journalist
Founder & President
International Coalition of Advocates for the People

Leslie Botha
Researcher and Broadcast Journalist
International Coalition of Advocates for the People

Treatise on Gardasil from the United States

United States Concern for Europe with regards to Cervarix HPV vaccine

United Kingdom Concerns Regarding HPV-GM Vaccines

The Dutch Cervarix Concerns

One Mother’s Plea


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.


  1. tina howard says:

    my daughter 18 had a papsmear 12 mths ago and was clear from hpv. she then at the same time as having pap smear had her gardisil injection. 12 mths later she has stage 1 of cervicil cancer. is gardisil responsible. my mother and grnd mother both died from the disease. what research is there in australia.

  2. Tina I am sorry to hear about your daughter. I have forwarded your concerns on to a couple of colleagues including Dr. Moulden who may have some answers. Cynthia Janak who I also emailed has contacts in Australia who may be helpful. I will forward their responses on to you.

    In the meantime check out the Global Concerns About Gardasil page on my site. We have put together about documentation that went out to scientists and politicians world wide about Gardasil. I have pulled this paragraph from the report that addresses your concern.

    2.4 In the (US Food and Drug Administration)VRBPAC Background Document, May 16, 2008 “Future l & ll Study Female subjects 16-23 years of age with normal baseline pelvic examinations were eligible for enrollment and were not prescreened for HPV prior to randomization.” 8 Concerns Regarding Primary Endpoint Analyses among Subgroups cited that “there were two important concerns identified during the course of the efficacy review. One was the potential for Gardasil™ to enhance disease among a subgroup of subjects who had evidence of persistent infection with vaccine-relevant HPV types at baseline. The other concern was the observations of CIN 2/3 or worse cases –44.6% due to HPV types not contained in the vaccine. These cases of disease due to other HPV types have the potential to counter the efficacy results of Gardasil™ for the HPV types contained in the vaccine.”

Speak Your Mind